Martin Madaus Elected to Haemonetics Board of Directors
Martin Madaus has been elected to the Haemonetics Board of Directors, effective July 24, 2026. Dr. Madaus brings over 30 years of leadership experience in diagnostics and life sciences, currently serving as a Senior Operating Executive at The Carlyle Group, and previously as CEO of Ortho Clinical Diagnostics and Millipore Corporation.
AI analysis
The rest of the AI analysis, red flags and sentiment are part of Signal8 Pro.
AI-generated analysis of a public disclosure. Not investment advice; verify against the original document.